<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The pathophysiology and appropriate pharmacological interventions for delusional <z:e sem="disease" ids="C0030499" disease_type="Disease or Syndrome" abbrv="">parasitosis</z:e> (DP) remain unknown </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we present a case of DP following <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> of the right temporoparietal region </plain></SENT>
<SENT sid="2" pm="."><plain>Pharmacotherapy with <z:chebi fb="0" ids="8871">risperidone</z:chebi> resulted in a dramatic therapeutic response over a short period </plain></SENT>
<SENT sid="3" pm="."><plain>In a sequential N-<z:chebi fb="0" ids="30353">isopropyl</z:chebi>-p-[(123)I]-iodoamphetamine single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomography ([(123)I]-<z:chebi fb="54" ids="17202">IMP</z:chebi> SPECT) study, post-treatment SPECT images revealed a marked increase of rCBF in the large areas including the bilateral frontal and left temporoparietal regions, the right parietal operculum and the bilateral basal ganglia, in contrast to pre-treatment SPECT images showing a global decrease of rCBF </plain></SENT>
<SENT sid="4" pm="."><plain>Our clinical outcome suggests the efficacy and safety of <z:chebi fb="0" ids="8871">risperidone</z:chebi> for treatment of DP and that both dopaminergic and serotonergic dysfunction may play a role in DP </plain></SENT>
<SENT sid="5" pm="."><plain>Our sequential SPECT findings suggest that psychiatric improvement of DP is associated with increased rCBF </plain></SENT>
</text></document>